-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Sell on Ginkgo Bioworks Holdings, Lowers Price Target to $5

Benzinga·03/12/2026 11:12:56
Listen to the news
BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target from $9 to $5.